PTGX RSI Chart
Last 7 days
-0.2%
Last 30 days
1.6%
Last 90 days
26.2%
Trailing 12 Months
39.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 60.0M |
2022 | 46.9M | 45.5M | 35.2M | 26.6M |
2021 | 31.2M | 27.2M | 24.4M | 27.4M |
2020 | 20.0M | 22.8M | 25.7M | 28.6M |
2019 | 21.7M | 0 | 14.2M | 17.1M |
2018 | 31.3M | 42.5M | 39.9M | 30.9M |
2017 | 0 | 0 | 0 | 20.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 07, 2024 | selick harold e | acquired | 12,266 | 1.89 | 6,490 | - |
Mar 01, 2024 | waddill william d. | sold | -406,636 | 31.34 | -12,975 | - |
Mar 01, 2024 | patel dinesh v ph d | sold | -948,600 | 31.62 | -30,000 | president and ceo |
Mar 01, 2024 | waddill william d. | acquired | 79,017 | 6.09 | 12,975 | - |
Mar 01, 2024 | ali asif | acquired | 146,040 | 12.17 | 12,000 | chief financial officer |
Mar 01, 2024 | ali asif | sold | -459,318 | 32.2374 | -14,248 | chief financial officer |
Feb 29, 2024 | ali asif | sold | -305,048 | 30.692 | -9,939 | chief financial officer |
Feb 26, 2024 | patel dinesh v ph d | sold (taxes) | -322,320 | 29.53 | -10,915 | president and ceo |
Feb 26, 2024 | gupta suneel | sold (taxes) | -126,447 | 29.53 | -4,282 | chief development officer |
Feb 15, 2024 | patel dinesh v ph d | sold (taxes) | -104,931 | 28.23 | -3,717 | president and ceo |
Which funds bought or sold PTGX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -95.65 | -1,803 | 115 | -% |
Mar 21, 2024 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | sold off | -100 | -1,467,840 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -2.31 | 18,469,700 | 72,319,300 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 120 | 15,835,000 | 23,628,000 | -% |
Mar 01, 2024 | READYSTATE ASSET MANAGEMENT LP | reduced | -68.97 | -1,763,170 | 1,311,730 | 0.04% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 175,520 | 650,983 | -% |
Feb 26, 2024 | PERCEPTIVE ADVISORS LLC | reduced | -63.65 | -8,797,120 | 8,788,150 | 0.20% |
Feb 20, 2024 | EVENTIDE ASSET MANAGEMENT, LLC | sold off | -100 | -5,337,600 | - | -% |
Feb 20, 2024 | Quarry LP | new | - | 17,198 | 17,198 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 454,000 | 454,000 | 0.04% |
Unveiling Protagonist Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Protagonist Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 40.7B | 6.8B | -8.64 | 5.95 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.8B | 1.8B | -42.76 | 10.3 | ||||
BMRN | 16.5B | 2.4B | 98.3 | 6.81 | ||||
INCY | 12.8B | 3.7B | 21.4 | 3.46 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.41 | 17.87 | ||||
BBIO | 5.4B | - | -8.32 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.8 | 13.97 | ||||
ARWR | 3.5B | 240.7M | -11.94 | 14.72 | ||||
ACAD | 3.0B | 726.4M | -49.71 | 4.19 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.31 | 4.72 | ||||
NVAX | 669.0M | 983.7M | -1.23 | 0.68 | ||||
CRBP | 411.7M | 881.7K | -9.23 | 466.16 | ||||
INO | 324.4M | 4.9M | -2.4 | 66.66 | ||||
IBIO | 14.1M | 2.1M | -0.52 | 2.14 |
Protagonist Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 |
Revenue | - | - | - | 19,000 | 859,000 | 25,722,000 | 8,617,000 | 10,286,000 | 2,265,000 | 6,189,000 | 5,650,000 | 13,114,000 | 6,217,000 | 3,647,000 | 3,894,000 | 4,141,000 | 1,560,000 | 2,353,000 | 6,117,000 | 11,674,000 | 10,781,000 | 11,282,000 |
Operating Expenses | 1.2% | 36,951,000 | 36,516,000 | 32,303,000 | 42,302,000 | 46,833,000 | 45,633,000 | 44,212,000 | 33,147,000 | 30,210,000 | 24,480,000 | 20,886,000 | 24,434,000 | 23,344,000 | 20,018,000 | 21,308,000 | 16,208,000 | 17,765,000 | 15,506,000 | 20,913,000 | 19,010,000 | - |
S&GA Expenses | 21.4% | 8,052,000 | 6,632,000 | 6,901,000 | 7,691,000 | 10,515,000 | 7,260,000 | 7,256,000 | 6,715,000 | 5,965,000 | 4,994,000 | 4,891,000 | 4,177,000 | 4,576,000 | 4,107,000 | 4,015,000 | 3,764,000 | 3,516,500 | 3,361,000 | 3,178,000 | 3,642,000 | - |
R&D Expenses | -3.3% | 28,899,000 | 29,884,000 | 25,402,000 | 34,611,000 | 36,318,000 | 38,373,000 | 36,956,000 | 26,432,000 | 24,245,000 | 19,486,000 | 15,995,000 | 20,257,000 | 18,768,000 | 15,911,000 | 17,293,000 | 12,444,000 | 14,248,500 | 12,145,000 | 17,735,000 | 15,368,000 | - |
EBITDA Margin | 55.7% | -2.11 | -4.75 | -3.54 | -2.74 | -2.66 | -4.56 | -4.35 | -2.94 | -2.16 | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | 127,000 | 19,000 | 209,000 | 243,000 | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | 5,000 | - | 1,100,000 | 200,000 | 817,500 | -100,000 | 183,000 | -799,000 | - | - | - | - |
Earnings Before Taxes | - | - | - | - | - | - | -36,907,000 | -33,804,000 | -30,842,000 | -23,998,000 | -18,886,000 | -7,763,000 | -18,292,000 | -19,904,000 | -16,644,500 | -16,511,000 | -13,920,000 | -14,664,000 | -8,735,000 | -8,663,000 | -7,661,000 | - |
EBT Margin | 55.7% | -2.12 | -4.79 | -3.57 | -2.76 | -2.68 | -4.59 | -4.41 | -2.99 | -2.21 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 179.9% | 27,335,000 | -34,194,000 | -31,232,000 | -41,037,000 | -20,930,000 | -36,907,000 | -33,804,000 | -30,842,000 | -23,998,000 | -18,886,000 | -7,763,000 | -19,421,000 | -20,080,000 | -17,501,000 | -16,409,000 | -14,103,000 | -13,865,000 | -8,735,000 | -8,663,000 | -7,661,000 | - |
Net Income Margin | 72.5% | -1.32 | -4.79 | -3.70 | -2.92 | -2.61 | -4.59 | -4.41 | -2.99 | -2.25 | -2.31 | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 153.4% | 16,941,000 | -31,705,000 | -25,363,000 | -13,925,000 | -37,939,000 | -27,135,000 | -28,735,000 | -24,200,000 | -28,896,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 8.5% | 358 | 330 | 320 | 240 | 248 | 282 | 311 | 348 | 348 | 373 | 404 | 298 | 324 | 217 | 225 | 135 | 155 | 155 | 148 | 132 | 139 |
Current Assets | 9.4% | 356 | 325 | 317 | 236 | 243 | 277 | 304 | 342 | 341 | 328 | 372 | 286 | 316 | 204 | 217 | 126 | 145 | 144 | 137 | 123 | 138 |
Cash Equivalents | -19.0% | 187 | 231 | 235 | 128 | 126 | 153 | 120 | 98.00 | 124 | 121 | 192 | 83.00 | 118 | 84.00 | 146 | 60.00 | 33.00 | 50.00 | 71.00 | 70.00 | 83.00 |
Net PPE | -15.9% | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
Liabilities | -23.7% | 21.00 | 28.00 | 26.00 | 24.00 | 32.00 | 39.00 | 43.00 | 47.00 | 48.00 | 44.00 | 47.00 | 39.00 | 45.00 | 48.00 | 57.00 | 72.00 | 75.00 | 59.00 | 64.00 | 31.00 | 27.00 |
Current Liabilities | -23.7% | 21.00 | 28.00 | 26.00 | 23.00 | 31.00 | 37.00 | 40.00 | 43.00 | 44.00 | 39.00 | 43.00 | 35.00 | 40.00 | 39.00 | 35.00 | 36.00 | 35.00 | 31.00 | 33.00 | 24.00 | 26.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.00 | 10.00 | - | - | - | - |
Shareholder's Equity | 11.4% | 337 | 302 | 294 | 216 | 216 | 244 | 268 | 302 | 300 | 330 | 357 | 259 | 280 | 170 | 167 | 63.00 | 80.00 | 95.00 | 84.00 | 101 | 113 |
Retained Earnings | 4.2% | -615 | -643 | -608 | -570 | -536 | -502 | -471 | -430 | -409 | -372 | -338 | -307 | -283 | -264 | -257 | -237 | -217 | -200 | -183 | -154 | -140 |
Additional Paid-In Capital | 0.8% | 952 | 945 | 903 | 787 | 753 | 747 | 740 | 733 | 710 | 702 | 696 | 567 | 563 | 435 | 425 | 300 | 298 | 296 | 268 | 256 | 253 |
Shares Outstanding | 0.1% | 58.00 | 58.00 | 57.00 | 51.00 | 49.00 | 49.00 | 49.00 | 49.00 | 46.00 | 48.00 | 45.00 | 44.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 1,600 | - | - | - | 379,500 | - | - | - | 2,100 | - | - | - | 641 | - | - | - | 212 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 163.7% | 16,960 | -26,611 | -26,238 | -34,347 | -31,635 | -25,201 | -13,635 | -37,666 | -26,939 | -28,470 | -23,700 | -28,756 | -18,867 | -16,287 | -21,482 | -15,848 | -14,289 | -14,246 | 3,670 | -16,662 | -10,135 |
Share Based Compensation | -2.4% | 6,601 | 6,765 | 8,343 | 7,584 | 5,512 | 5,950 | 6,805 | 5,935 | 5,024 | 4,775 | 3,936 | 2,660 | 1,967 | 1,888 | 1,996 | 2,048 | 2,160 | 2,201 | 2,013 | 1,979 | 2,072 |
Cashflow From Investing | -352.0% | -61,287 | -13,559 | 25,762 | 9,826 | 3,935 | 57,275 | 34,734 | -4,476 | 27,867 | -44,707 | 7,773 | -6,793 | -74,402 | -54,122 | -5,171 | 42,730 | -12,554 | -32,039 | -13,225 | 4,108 | 4,549 |
Cashflow From Financing | -98.5% | 527 | 35,315 | 108,172 | 26,463 | 553 | 680 | 680 | 16,925 | 2,173 | 1,381 | 125,390 | 979 | 126,981 | 7,669 | 112,577 | 399 | 9,779 | 25,237 | 10,630 | 390 | 479 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Consolidated Statements of Operations | |||
License and collaboration revenue | $ 60,000 | $ 26,581 | $ 27,357 |
Revenue from Contract with Customer, Product and Service [Extensible List] | License and Collaboration Agreement | License and Collaboration Agreement | License and Collaboration Agreement |
Operating expenses: | |||
Research and development | $ 120,161 | $ 126,215 | $ 126,006 |
General and administrative | 33,491 | 31,739 | 27,196 |
Total operating expenses | 153,652 | 157,954 | 153,202 |
Loss from operations | (93,652) | (131,373) | (125,845) |
Interest income | 14,898 | 4,060 | 443 |
Other expense, net | (201) | (80) | (149) |
Net loss | $ (78,955) | $ (127,393) | $ (125,551) |
Net loss per share, basic | $ (1.39) | $ (2.60) | $ (2.71) |
Net loss per share, diluted | $ (1.39) | $ (2.60) | $ (2.71) |
Weighted-average shares used to compute net loss per share, basic | 56,763,559 | 49,042,232 | 46,322,910 |
Weighted-average shares used to compute net loss per share, diluted | 56,763,559 | 49,042,232 | 46,322,910 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 186,727 | $ 125,744 |
Marketable securities | 154,890 | 111,611 |
Receivable from collaboration partner | 10,000 | 10 |
Prepaid expenses and other current assets | 3,960 | 5,712 |
Total current assets | 355,577 | 243,077 |
Property and equipment, net | 1,195 | 1,565 |
Restricted cash - noncurrent | 225 | 225 |
Operating lease right-of-use asset | 954 | 3,061 |
Total assets | 357,951 | 247,928 |
Current liabilities: | ||
Accounts payable | 772 | 3,640 |
Payable to collaboration partner | 3 | 69 |
Accrued expenses and other payables | 19,358 | 24,955 |
Operating lease liability - current | 1,141 | 2,515 |
Total current liabilities | 21,274 | 31,179 |
Operating lease liability - noncurrent | 1,141 | |
Total liabilities | 21,274 | 32,320 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.00001 par value, 10,000,000 shares authorized; no shares issued and outstanding | ||
Common stock, $0.00001 par value, 90,000,000 shares authorized; 57,708,613 and 49,339,252 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 1 | |
Additional paid-in capital | 952,491 | 752,722 |
Accumulated other comprehensive loss | (105) | (359) |
Accumulated deficit | (615,710) | (536,755) |
Total stockholders' equity | 336,677 | 215,608 |
Total liabilities and stockholders' equity | $ 357,951 | $ 247,928 |